Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update
● Total revenues for the third quarter 2024 were $9.0 million, an increase of 1.5% from Q3 2023. Revenue […]
Sysco Las Vegas Donates 2,500 Turkeys to Feed Those in Need This Thanksgiving
LAS VEGAS, Nov. 13, 2024 (GLOBE NEWSWIRE) — Today, Sysco Corporation (NYSE:SYY), the world’s largest food distributor, presented a check […]
Cheetah Net Supply Chain Service Inc. Announces Third Quarter 2024 Results and Provides Corporate Update
IRVINE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) — Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq CM: […]
Bluejay Diagnostics Announces Reverse Stock Split
ACTON, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) — Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology […]
EZCORP Reports Fourth Quarter and Full Year Fiscal 2024 Results
AUSTIN, Texas, Nov. 13, 2024 (GLOBE NEWSWIRE) — EZCORP, Inc. (NASDAQ: EZPW), a leading provider of pawn transactions in the […]
SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update
DENVER, Nov. 13, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a commercial-stage […]
Ellsworth Growth and Income Fund Ltd. Declares Distribution of $0.14 per Share
RYE, N.Y., Nov. 13, 2024 (GLOBE NEWSWIRE) — The Board of Trustees of Ellsworth Growth and Income Fund Ltd. (NYSE […]
TSX News -
Element Reports Record Third Quarter Results, Raises Common Dividend, and Provides Full-Year 2025 Guidance
Amounts in US$ unless otherwise noted Generates record quarterly net revenue of $280 million; an increase of 12% year-over-year led by […]
Shuttle Pharma Provides Third Quarter 2024 Corporate Update
GAITHERSBURG, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a […]
Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical […]
